Antithrombotic biological agent prepared by adopting nereis active peptide

A biological preparation and antithrombotic technology, applied in the preparation method of peptides, organic active ingredients, medical preparations containing active ingredients, etc., to achieve good stability, good medical application value, and increase the effect of economic added value
CN106563120AActive Publication Date: 2017-04-19ZHEJIANG OCEAN UNIV
1 Cites 3 Cited by

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
ZHEJIANG OCEAN UNIV
Publication Date
2017-04-19

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention discloses an antithrombotic biological agent prepared by adopting nereis active peptide. The antithrombotic biological agent is prepared by mixing the following components in parts by weight: 10-20 parts of nereis anticoagulant peptide, 1-5 parts of heparin sodium, and 100 parts of a carrier. The antithrombotic biological agent is good in stability and anticoagulation activity, has the antithrombus function, and has the good medical application value, and the economic additional value of nereis is increased.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to an antithrombotic preparation, in particular to an antithrombotic biological preparation prepared by using nereis active peptide. Background technique

[0002] Thrombosis is the common pathological basis of ischemic heart disease, ischemic stroke and venous thrombosis, which seriously endangers human health and has been increasing in recent years. Inhibition of platelet aggregation and release, inhibition of thrombin system, activation of antithrombin and plasmin system can inhibit thrombus formation. The formation of thrombus is the main pathological process of ischemic cardiovascular and cerebrovascular diseases and thromboembolic diseases, and is closely related to the occurrence and development of diseases. Therefore, inhibiting platelet aggregation and thrombus formation is of great significance to the prevention and treatment of cardiovascular and cerebrovascular diseases and other thromboembolic diseases.

[0003] Hepa...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More